There have been no comprehensive studies that have compared the incidence of symptomatic VTE over a spectrum of different urgent or elective surgical procedures. In this study we determined the incidence of symptomatic venous thromboembolic events (VTE) within a 3 month period after 76 different surgical procedures. Using a large administrative data-base, we analyzed 1,653,275 cases that underwent one of 76 selected surgical procedures between January 1, 1992 and September 30, 1996. The principal outcomes were venous thrombosis or pulmonary embolism, during either the initial hospitalization or a re-hospitalization for VTE within 91 days of the date of surgery. Predictors of VTE were analyzed using logistic regression. Overall, VTE was diagnosed in 13,533 cases (0.8%, 95% CI = 0.7-0.9%) and of these, 5049 (37%, 95% CI = 36-38%) had pulmonary embolism. Predictors of VTE included: advancing age (OR=1.1 per 5 year increment in age, 95% CI =1.1-1.1), Latino ethnicity (OR = 0.9, 95% CI =0.8-0.9), Asian/Pacific Islander ethnicity (OR = 0.5, 95% CI = 0.4-0.6), presence of a malignancy (OR = 1.7, 95% CI = 1.6-1.8) and prior VTE (OR = 6.2, 95% CI = 5.5-7.0). High-risk procedures that had an incidence of symptomatic VTE of approximately 2 to 3% included invasive neurosurgery, total hip arthroplasty, major vascular surgery and radical cystectomy. Fifty-six percent of all VTE events diagnosed within 91 days of surgery occurred after discharge. The findings of this study provide a basis for categorizing different surgical procedures as low, intermediate, high and very high risk for VTE. Because of the high incidence of VTE diagnosed after hospital discharge, further studies of extended thromboprophylaxis appear warranted.
Keywords
Thromboembolism -
surgery -
complications -
venous thrombosis -
epidemiology
References
1
Geerts WH,
Heit JA,
Clagett GP.
et al. Prevention of venous thromboembolism. Chest 2001; 119 (Suppl. 01) (Suppl) 132S-75S.
2
Colwell Jr. CW,
Collis DK,
Paulson R.
et al. Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge. J Bone Joint Surg Am 1999; 81 (07) 932-40.
3
White RH,
Romano PS,
Zhou H.
et al. Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch Intern Med 1998; 158 (14) 1525-31.
4
Trowbridge A,
Boese CK,
Woodruff B.
et al. Incidence of posthospitalization proximal deep venous thrombosis after total hip arthroplasty. A pilot study. Clin Orthop 1994; 299: 203-8.
6
Sorensen HT,
Mellemkjaer L,
Steffensen FH.
et al. The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N Engl J Med 1998; 338 (17) 1169-73.
8
Meux EF,
Stith SA,
Zach A..
Report of results from the OSHPD reabstracting project: An evaluation of the reliability of selected patient discharge data, July through December 1988. Office of Statewide Health Planning and Development 1990.
10
White RH,
Zhou H,
Romano PS.
Length of hospital stay for treatment of deep venous thrombosis and the incidence of recurrent thromboembolism. Arch Intern Med 1998; 158 (09) 1005-10.
11
Romano PS,
Roos LL,
Luft HS.
et al. A comparison of administrative versus clinical data: coronary artery bypass surgery as an example. Ischemic Heart Disease Patient Outcomes Research Team. J Clin Epidemiol 1994; 47 (03) 249-60.
12
White RH,
Zhou H,
Romano PS.
Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Ann Intern Med 1998; 128 (09) 737-40.
13
Bucher HC,
Guyatt GH,
Cook DJ.
et al. Users’ guides to the medical literature: XIX. Applying clinical trial results. A. How to use an article measuring the effect of an intervention on surrogate end points. Evidence-Based Medicine Working Group. JAMA 1999; 282 (08) 771-8.
14
Anderson Jr. FA,
Wheeler HB,
Goldberg RJ.
et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 1991; 151 (05) 933-8.
15
Silverstein MD,
Heit JA,
Mohr DN.
et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998; 158 (06) 585-93.
16
Heit JA,
Silverstein MD,
Mohr DN.
et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 2000; 160 (06) 809-15.
17
Raabe A,
Gerlach R,
Zimmermann M,
Seifert V.
Practice of perioperative thromboembolic prophylaxis in neurosurgery: results of a German survey. Zentralbl Neurochir 2000; 61 (02) 103-10.
19
Hollyoak M,
Woodruff P,
Muller M.
et al. Deep venous thrombosis in postoperative vascular surgical patients: a frequent finding without prophylaxis. J Vasc Surg 2001; 34 (04) 656-60.
20
Olin JW,
Graor RA,
O’Hara P,
Young JR.
The incidence of deep venous thrombosis in patients undergoing abdominal aortic aneurysm resection. J Vasc Surg 1993; 18 (06) 1037-41.
25
Prandoni P,
Bruchi O,
Sabbion P.
et al. Prolonged thromboprophylaxis with oral anticoagulants after total hip arthroplasty: a prospective controlled randomized study. Arch Intern Med 2002; 162 (17) 1966-71.
27
Samama CM,
Vray M,
Barre J.
et al. Extended venous thromboembolism prophylaxis after total hip replacement: a comparison of low-molecular-weight heparin with oral anticoagulant. Arch Intern Med 2002; 162 (19) 2191-6.
28
White RH,
Gettner S,
Newman JM.
et al. Predictors of rehospitalization for symptomatic venous thromboembolism after total hip arthroplasty. N Engl J Med 2000; 343 (24) 1758-64.
29
Douketis JD,
Eikelboom JW,
Quinlan DJ.
et al. Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes. Arch Intern Med 2002; 162 (13) 1465-71.
30
Mantilla CB,
Horlocker TT,
Schroeder DR.
et al. Frequency of myocardial infarction, pulmonary embolism, deep venous thrombosis, and death following primary hip or knee arthroplasty. Anesthesiology 2002; 96 (05) 1140-6.
31
Donat R,
Mancey-Jones B.
Incidence of thromboembolism after transurethral resection of the prostate (TURP)—a study on TED stocking prophylaxis and literature review. Scand J Urol Nephrol 2002; 36 (02) 119-23.
32
Moreano EH,
Hutchison JL,
McCulloch TM.
et al. Incidence of deep venous thrombosis and pulmonary embolism in otolaryngology-head and neck surgery. Otolaryngol Head Neck Surg 1998; 118 (06) 777-84.
33
Stratton MA,
Anderson FA,
Bussey HI.
et al. Prevention of venous thromboembolism: adherence to the 1995 American College of Chest Physicians consensus guidelines for surgical patients. Arch Intern Med 2000; 160 (03) 334-40.
35
Walker N,
Rodgers A,
Gray H.
Changing patterns of pharmacological thromboprophylaxis use by orthopaedic surgeons in New Zealand. ANZ J Surg 2002; 72 (05) 335-8.
36
Goldhaber SZ,
Dunn K,
MacDougall RC.
New onset of venous thromboembolism among hospitalized patients at Brigham and Women’s Hospital is caused more often by prophylaxis failure than by withholding treatment. Chest 2000; 118 (06) 1680-4.
37
Caprini JA,
Arcelus J,
Sehgal LR.
et al. The use of low molecular weight heparins for the prevention of postoperative venous thromboembolism in general surgery. A survey of practice in the United States. Int Angiol 2002; 21 (01) 78-85.
38
Caprini JA,
Arcelus JI,
Hoffman K.
et al. Prevention of venous thromboembolism in North America: results of a survey among general surgeons. J Vasc Surg 1994; 20 (05) 751-8.
